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Successful scaling up of mental health services involves putting
together a range of human, physical and other resource inputs
in order to deliver interventions and services capable of improving
mental health and related outcomes.1 Accordingly, an essential
element of evidence-based mental health service planning and
scale up relates to an assessment of what resources are required
to deliver services to the population in need and meet programme
goals.
In this paper, one of a series describing the development of
district-level mental healthcare plans (MHCPs) in five low- and
middle-income countries (LMIC) participating in the
PRogramme for Improving Mental health carE (PRIME) study,
the expected resource needs and costs of implementing and scaling
up services in these localities are presented and examined. The
work builds on earlier methods and analysis undertaken for
12 LMIC,2 but is pitched at the district rather than national level,
is more closely based on local experiences and data, and employs a
more extensive costing tool for estimation.
Method
Setting
In line with other papers in this supplement, analysis of resource
needs and costs was carried out for five districts in sub-Saharan
Africa and south Asia that span a diverse range of sociocultural,
urban/rural and economic contexts, including extremely under-
resourced settings (Ethiopia, Uganda), a fragile state setting
(Nepal) and middle-income countries marked by high levels of
socioeconomic inequality (India and South Africa). Key socio-
demographic, epidemiological and economic characteristics of
each study district, including estimates of population in need,
are shown in Table 1.3,4
MHCPs and intervention packages
The formation and specification of each district-level MHCP
is described in detail in the companion papers in this
supplement.5–9 The specific disorders and interventions included
in each country site’s plan, together with current and target
coverage levels, are shown in Table 2. All sites included treatment
of psychosis, depression and alcohol use disorders, and three sites
(Ethiopia, Nepal, Uganda) also included epilepsy treatment. The
primary source for the selection of interventions was the World
Health Organization (WHO) Mental Health Gap Action
Programme (mhGAP) intervention guide,10 which was adapted
according to local district needs in each PRIME country site.
Assessment of resource needs and costs
The newly developed mhGAP costing tool was used to estimate
resource requirements and costs of each site’s intervention package
(tool available from the authors on request). This is a disease-
specific costing tool for short- or medium-term planning that
can be used to generate forecasts of human and financial resource
needs (at the national or subnational level); it is based on a
methodology used to derive global cost estimates for scaling up
interventions related to the Millennium Development Goals, such
as HIV/AIDS,malaria and child health, as well as non-communicable
diseases and mental health.2,11 The tool produces estimates of total
and incremental costs of scaled-up provision, broken down by
different mhGAP disorders, types of expenditure and year of scale
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Background
An essential element of mental health service scale up
relates to an assessment of resource requirements and cost
implications.
Aims
To assess the expected resource needs of scaling up
services in five districts in sub-Saharan Africa and south
Asia.
Method
The resource quantities associated with each site’s specified
care package were identified and subsequently costed, both
at current and target levels of coverage.
Results
The cost of the care package at target coverage ranged
from US$0.21 to 0.56 per head of population in four of the
districts (in the higher-income context of South Africa, it was
US$1.86). In all districts, the additional amount needed each
year to reach target coverage goals after 10 years was
below $0.10 per head of population.
Conclusions
Estimation of resource needs and costs for district-level
mental health services provides relevant information
concerning the financial feasibility of locally developed plans
for successful scale up.
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up. Costs can be calculated in local currency units or inUS dollars. All
prices and cost values reported here are in US dollars for 2008 (no
account is taken of inflation).
The cost of scaling up an intervention can be determined with
reference to five key parameters:
(a) population (of the country, region or district);
(b) prevalence (of the disorder in question);
(c) resource quantities (needed for an intervention; for example
out-patient visits, medicines);
(d) prices or unit costs (for each resource item or entity; for
example salaries, drug prices); and
(e) coverage (% population in need that receives the intervention).
Multiplication of the first two parameters (population6
prevalence) defines the population at risk or in need (Table 1),
whereas multiplication of the final two parameters (resource
use6price) provides the cost per case treated (Table 3). The
remaining parameter, coverage, acts as the lever through which
the total number (and associated cost) of treated cases can be
estimated over a period of scaled-up service delivery (Table 2).
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Population, n 165 000 1 311 008 566 661 796 823 428 500
Living rurally, % 90 81 73 14 97
Literacy rate, % 22 71 70 88 62
Health spend per capita (nationally, US$)a 7 29 17 425 24
Cases, n (% population in need)b
Depression 1615 (1.0) 19 423 (1.5) 8126 (1.4) 15 931 (2.3) 3879 (0.9)
Psychosis 481 (0.3) 4679 (0.4) 1881 (0.3) 2533 (0.4) 1114 (0.3)
Epilepsy 2342 (1.4) – 3418 (0.6) – 6114 (1.4)
Alcohol use disorders 8379 (5.1) 7525 (0.6) 3006 (0.5) 13 851 (2.0) 19 205 (4.5)
a. Source: World Health Organization (WHO) National Health Accounts database (www.who.int/nha/country/en/).
b. Source: WHO Global Burden of Disease database (www.who.int/healthinfo/global_burden_disease/en/).
Table 2 District-level intervention packages and coverage levels
Sodo district (Ethiopia) Sehore district (India) Chitwan district (Nepal)
Kenneth Kaunda district
(South Africa) Kamuli district (Uganda)
Disorder and
Coverage, %




and follow-up 5 35 5 30 1 30 5 15 5 50
Antidepressant
medication 5 30 5 30 1 30 15 25 3 30
Intensive psycho-
social intervention 1 15 0 5
Psychosocial care
for perinatal




and follow-up 10 75 20 60 1 40 20 30 10 80
Antipsychotic
medication 10 75 20 60 1 40 60 80 10 50
Intensive psycho-




and follow-up 13 75 – – 1 50 – – 30 80
Anti-epileptic




(of new cases) 2 25 5 20 1 30 1 20 1 30
Brief interventions
and follow-up 2 25 5 20 1 15 1 10 1 30
Management of
alcohol withdrawal 2 25 – – – – 5 20 1 20
Downloaded from https://www.cambridge.org/core. 10 Mar 2021 at 10:45:50, subject to the Cambridge Core terms of use.
Estimating the cost of implementing district mental healthcare plans
Population in need
The population in need in each district was calculated by relating
prevalence estimates for the different disorders to the total
population of the district. In the absence of robust local
psychiatric epidemiological surveys in all but one setting,
prevalence estimates were drawn from the Global Burden of
Disease database for the WHO subregion to which the country
in question belonged (www.who.int/healthinfo/global_burden_
disease/en/). In the South African district, the population in need
for treatment of depression and alcohol use disorders was revised
to cover only those with HIV and chronic non-communicable
diseases such as cardiovascular disease and diabetes (which is in
line with the national policy to roll-out an integrated system of
care for chronic diseases).
Resource quantities
Concerning healthcare resource profiles for each of the included
interventions, the key categories of potential resource use incurred
in non-specialist healthcare settings were: primary and ancillary
care visits; medication; and laboratory or diagnostic tests. In
addition, resources used at a higher, more specialised level of
the healthcare system were considered, in particular hospital
in-patient and out-patient services. Since specialist psychiatric
services are largely absent at the level of the participating districts,
the primary focus of the cost analysis was on non-specialised
healthcare needs; specialist services were included in a secondary
analysis in order to ascertain the likely range of costs that would
apply if they were available and utilised. Default estimates of
expected resource use were based on the treatment protocols laid
out in the mhGAP intervention guide, and supplemented by
information from cost-effectiveness studies of these interventions
in resource-constrained settings (for an overview see Chisholm &
Saxena12).13 However, since local practice or operationalisation
concerning these evidence-based interventions varies appreciably,
each district team reviewed and revised these profiles (see online
Table DS1 for a tabulated overview of changes made).
The mhGAP costing tool also provides indicative human and
other resource needs for overall mental health programme
direction and administration, as well as for training and capacity
building. As a result of the paucity of current mental health
programme activity in districts, baseline programme-level costs
were expected to be negligible. The cost of appropriate
programme management, training and supervision in each district
were estimated and are reported below.
Unit costs
The price or ‘unit cost’ of healthcare services and goods come in
two forms: ‘traded goods’, such as medicines or diagnostic
equipment (which can be purchased on the international market);
these items were valued at international price levels, adjusted
for shipping and distribution costs to/within a country (default
drug prices were taken from the International Drug Price Indicator
Guide http://erc.msh.org/dmpguide/). ‘Non-traded’ goods included
local personnel, in-patient and out-patient care, per diems for
training, consumables, building costs and utilities (which are
largely generated and used up within national boundaries); for
these items, country-specific predicted costs were entered, using
the WHO CHOICE costing database (www.who.int/choice/costs).
Only a small proportion of the unit cost of a healthcare visit is
for capital (a fixed cost), so the large majority of costs can be
considered variable. The analysis is based on the expected cost
to public health funding bodies and care providers. Each of the
unit cost estimates were reviewed and revised as appropriate by
site teams (Table DS1). For example, all countries revised the costs
of psychotropic medications from the default international rates
set in the mhGAP costing tool, as well as salary amounts; South
Africa revised upwards the unit costs of primary, secondary and
tertiary hospital care utilisation.
Coverage
Coverage refers to the proportion of people in need that receive a
specified intervention. Thus, a target coverage rate of 50% for
psychosis would mean that a half of all individuals with the
condition in the population are expected by the final year of scale
up to be actually accessing and receiving an intervention (for
example, basic psychosocial treatment plus antipsychotic
medication). Current coverage levels for each intervention were
derived for each site based on estimates of prevailing service
provision from local clinicians and national survey data; in many
cases current rates of treatment coverage are extremely low (Table
2). For target coverage, estimates were based on the considered
opinion of local research teams, taking into account expected
levels of political, financial and logistical support for mental health
service scale up (Table 2).
Analysis
Site-specific output from the mhGAP costing tool was analysed in
order to calculate costs per case and per capita for each disorder.
Calculations were then made of selected relevant outputs such as
total costs and incremental cost for packages of care and the
proportion of total costs spent on different cost categories. A
sensitivity analysis was also carried out on key cost drivers,
including in-patient costs, scale-up patterns and the inclusion of
inflation.
Results
Costs per case of disorder
The expected average annual cost of treating the different priority
disorders in the non-specialist healthcare setting of each
participating district is shown in Table 3. These are broken down
by specific intervention components as set out in the WHO
mhGAP intervention guide (for example basic psychosocial
treatment, advice and follow-up; medication; intensive psycho-
social treatments). In each of the five districts/countries, costs
are highest for psychosis – reflecting the need for frequent
follow-up visits as well as daily medication – and are particularly
elevated in Nepal and South Africa (driven by antipsychotic drug
costs). Costs are lowest for alcohol use disorders, reflecting lower
resource utilisation (for example, brief advice or counselling).
Costs per case in Ethiopia, India and Uganda are very comparable,
and considerably lower than in South Africa.
Resource needs and costs of scale up
Multiplying the above costs per average case of disorder by the
population in need (Table 1) and the proportion receiving
treatment in the baseline year (Table 2) gives the total cost of the
intervention package at current coverage levels. For example, the
current cost of treating psychosis with antipsychotic medication
and intensive psychosocial intervention in Sehore district in India
is estimated to be $28 261 (4679 cases620% coverage6$30.20
per case treated). For all disorders included in each district’s
mental healthcare plans, estimates of current cost ranged from
$10 000 to 20 000 in the Ethiopian and Nepalese districts to over
$700 000 in the South African district, equivalent to less than
$0.10 to just over $1.00 per capita when differences in district
s73
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population size are taken into account (Fig. 1). The total cost of
delivering the intervention package at target coverage levels is
naturally higher, ranging from $0.21 per capita in the Indian
district (60% higher than current costs) to $1.86 per capita in
South Africa (nearly 100% higher). Reflecting large changes in
coverage, Nepal had the greatest relative cost increase (over
threefold, from $0.04 to $0.56 per capita). In Ethiopia and
Uganda, the total cost at target coverage levels is projected to reach
$0.28–0.42 per capita.
The difference between the current and target levels of
treatment coverage gives the incremental cost of scaling up. The
amount of funding that needs to be invested per person per year
in order to move from current to target coverage levels depends on
the period of scale up (the longer the period, the less that is
needed per year). Figure 2 provides three time frames (5, 10
and 15 years) and their associated annual incremental cost values.
Results indicate that, over a 10-year scale-up period for example,
the additional amount that needs to be invested each year in all of
the country settings is less than $0.10 per capita. In the context of
Kamuli district in Uganda, for instance, the budget would need to
increase each year over the next decade by about $9500 (an extra
$0.02 per year for each of the 428 500 people living in the district);
if the aim were to achieve set target coverage levels within the next
5 years, the annual budget increase would need to double to
s74













Basic psychosocial treatment, advice
and follow-up
2.48 3.56 1.86 15.45 3.75
Antidepressant medication 33.50 11.83 29.63 55.92 11.25
Intensive psychosocial intervention – – 2.32 15.89 –
Psychosocial care for perinatal depression 5.05 14.48 – – 6.71
Psychosis
Basic psychosocial treatment, advice
and follow-up
8.60 5.35 2.79 23.17 9.12
Antipsychotic medication 35.29 30.20 176.47 357.87 22.84
Intensive psychosocial intervention – – 6.95 14.45 –
Epilepsy
Basic psychosocial treatment, advice
and follow-up
1.24 – 1.86 – 1.52
Anti-epileptic medication 13.32 – 37.00 – 13.77
Alcohol use disorder
Identification and assessment (of new cases) 0.40 1.14 0.60 4.95 0.61
Brief interventions and follow-up 1.24 3.56 1.86 28.05 1.90
Management of alcohol withdrawal 3.75 – – 35.42 0.80
a. Non-specialist care only (excludes hospital-based in-patient and out-patient care); cost per average case accounts for proportion of individuals needing the intervention (for example



















































































Fig. 1 Cost of mental healthcare plan package, at current and target coverage (US$ per capita).
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$19 000. For these analyses, a smooth linear pattern of scale up is
employed for all settings, but depending on the extent of local or
national stakeholder buy-in and logistical preparedness, the
pattern could very well take on either a front-loaded or a slower,
exponential trajectory.
Figure 3 provides a breakdown by category of cost in each of
the five districts. Ancillary care and diagnostic tests account
for only a small fraction; in the Ethiopian, Nepalese and South
African districts, at least half of the costs are attributable to
essential psychotropic medicines, with the remaining costs related
to primary care service delivery, in particular human resources.
Based on the total volume of expected visits and the working
conditions of healthcare providers, the mhGAP costing tool also
produces estimates of human resource need. Table 4 shows the
type and number of healthcare providers needed to deliver the
specified mental healthcare intervention package in each of the
districts at target levels of coverage. The estimated number of
full-time equivalent staff needed per 100 000 population ranges
from four to five in the Indian and South African districts to
nearly ten in the Ethiopian district; inter-site variations are
because of differences in the specified intervention package to
be provided (for example inclusion of epilepsy in the MHCP of
Uganda and Ethiopia) and associated coverage levels or resource
inputs (for example lower target coverage levels for psychosis
and epilepsy in Nepal than in Ethiopia and Uganda).
Secondary and sensitivity analyses
In line with the mhGAP intervention guide, but also reflecting the
very limited availability of specialist service in the five districts,
the baseline analysis presented above focuses on the care and
treatment of patients in non-specialist healthcare settings alone;
it does not include the costs associated with more specialist
hospital-based services that some individuals access and use, nor
does it include costs incurred above the provider facility level,
such as programme management, training and supervision.
Accordingly, further analysis was performed that included these








Kenneth Kaunda district (South Africa)
Kamuli district (Uganda)
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Fig. 3 Distribution of costs in non-specialised healthcare settings.
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are made available locally (in district general hospitals), or if
MHCP implementation leads to new referrals of individuals with
more severe conditions by non-specialist providers. Based on each
country team’s review of expected resource needs this included
hospital admission for a proportion of individuals (2% for
depression and alcohol use disorders, 5–10% with psychosis),
periodic out-patient visits (20–30% for psychosis, 15–20% for
other disorders) and the roll-out of mhGAP training programmes.
Results for this expanded cost scenario showed that programme
costs associated with training, supervision and management
added 5–15% to the baseline cost estimate, except in India where
the relative contribution is higher (28%). Incorporation of
hospital-based services added a similarly modest amount (8–13%)
to the baseline costs of the Ethiopian, Nepalese and Ugandan
districts (reflecting the low unit costs of providing these specialist
services in those settings) but increase costs in the Indian and
South African districts (nearly and more than doubling the final
cost, respectively). Figure 4 shows the revised costs of achieving
target coverage levels with these components added. A sensitivity
analysis was also undertaken to assess the impact of inflation
(baseline results are in constant values for the year 2008). Over
a 15-year-period of scale up, an inflation rate of 3% will increase




The cost analysis presented here was carried out to inform local
PRIME country teams about the expected resource implications
associated with the implementation of their respective MHCPs.
Such an analysis offers a complementary perspective to the
(largely qualitative) formative research that went into the
development of each site’s plan;5–9 it produces information about
the financial feasibility of these plans and can provide a ‘reality
check’ where plans exceed what is likely to be possible or available
in the future. Results indicate that, starting from an often very low
base of mental health service coverage, the cost of scaled-up
provision in non-specialist healthcare settings of an evidence-
based package of care range from US$0.20 to 0.56 per capita in
four out of the five districts assessed. For a district with a total
population of half a million, therefore, an annual outlay of
between US$100 000 and 300 000 would be required to reach the
target coverage levels specified here. The outlier is South Africa,
an upper-middle-income country where the prevailing price
and quantity of healthcare service inputs are that much higher
(to illustrate, total health spending per capita exceeds US$400
per year, compared with less than US$40 in the other four
countries); the cost per capita of delivering the specified care
package at target coverage levels in the South African district
approaches US$2 per capita. This is higher than in the other
countries but relatively low in the context of current health
spending levels in South Africa. As indicated in the South African
MHCP,8 mental health is incorporated within integrated chronic
disease management at primary care level. Given that the
additional cost of scaled-up provision will have to compete with
other priority chronic conditions, the need for cost–benefit studies
on the impact of integration on improved overall outcomes for
chronic care is highlighted in the case of South Africa.
Getting to target levels of annual spending in each district will
necessitate a steady budgetary increase, estimated at no more than
US$10 000 extra per year for a district with half a million people if
s76
Table 4 Human resource needs at target coverage levels of intervention package delivery in five non-specialised healthcare settings












Psychiatrist 0.0 0.2 0.3 0.2 0.0
Other physician/doctor 1.1 0.3 1.0 0.6 0.9
Nurse 4.2 1.9 2.5 1.7 4.7
Psychologist 0.0 0.3 0.3 0.3 0.0
Other psychosocial workers 2.1 0.6 1.3 0.8 0.9
Other providers/workersa 2.1 0.9 1.2 1.1 1.4
Total 9.5 4.2 6.6 4.7 7.9







Kenneth Kaunda district (South Africa)
Kamuli district (Uganda)
0 1.00 2.00 3.00 4.00
Total cost, all components US$ per capita
5.00
Fig. 4 Sensitivity analysis: influence of hospital-based service use and programme costs on baseline results.
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a 10-year period is used (even in the South African setting, since
current coverage levels are relatively higher than in the districts of
the other four sites). Extending the cost estimation to also take into
account programme management and utilisation of hospital-based
services by the district population in need increases these baseline
cost projections, substantially so in South Africa and India (by
as much as 100%), and modestly so in the other three sites (by
approximately 20%). These upper cost estimates amount to only
1% of total current health spending per capita in the South
African context, but reach up to 7% in Ethiopia.
Even with these additional cost elements of specialist care,
programme management and training factored in, the present cost
estimates are lower than those reported earlier for a similar mental
healthcare package in a number of LMICs (including Ethiopia and
Nepal), which suggested an indicative investment of US$2.00 per
capita for low-income countries.2 This reflects the use of (and
pragmatic need for) a more selective range of interventions and
less intensive resource utilisation per treated case. In this sense,
the current work provides a more realistic or locally grounded
estimate of what can be achieved, and at what cost. Such a
selective approach was also used recently in the context of the
prevention and control of non-communicable diseases, which
showed that the scaling up of a set of so-called ‘best buys’ would
be expected to cost below US$1 in low-income countries, less than
US$1.50 in lower-middle-income countries and US$2.50 in
upper-middle-income countries.11
Key cost drivers
Underlying these summary cost measures of programme needs
and gaps, there are a number of key cost drivers at work in the
different country contexts. One relates to local drug prices, which
help to keep acquisition costs down in India but accounts for a
large share of total cost in neighbouring Nepal as well as South
Africa. Accordingly, where prices of essential psychotropic
medicines represents a large share of spending, this could be a
particular issue to investigate. A further critical category of cost
concerns human resources and the specific type of worker that will
undertake particular mental healthcare tasks or duties. For
example, the community-based service model envisaged for scale
up in Ethiopia assumes that no psychiatrist will be available within
the district and that health extension workers will form the
backbone of service provision. Therefore, appropriate policies
and processes for the successful recruitment, training and
retention of community-based mental health workers can be
expected to have a major bearing on financial flows over time.
Finally, the finding that costs increase most in South Africa and
India when specialist services were included shows how
hospital-based in-patient and out-patient care exerts an
increasingly important influence on overall costs as national
income rises. In low-income countries, an in-patient day often
costs less than $10, and therefore has less impact on total costs;
in high-income countries, by contrast, where one in-patient day
typically costs hundreds of dollars, this is a critical driver of cost.
These sources of variation between different national settings
points to the need for context-specific data and analysis, which
is very much what the mhGAP costing tool (available from the
authors on request) is geared towards.
Such differences in the structure of costs make comparison
between studies very hard, particularly between high- v. low- or
middle-income countries. Nevertheless, other economic studies
provide insights into average treatment costs for treating mental
disorders in a range of settings. Using older antidepressant drugs
and providing stepped care tailored to the needs of the patient, for
example, has relatively low annual costs per case of depression,
from US$107 in India to under US$200 in Nigeria.12,14 Similarly,
the annual cost per treated case of epilepsy is relatively low; for
example in Nigeria, older anti-epileptic drugs are less than
US$100 per patient per year.14 In line with the evidence presented
here, schizophrenia is generally more expensive to treat per person
than either depression or epilepsy, especially if newer
antipsychotic medications are used. In Nigeria, treating
schizophrenia with older antipsychotic drugs falls between
US$200 and 300, whereas newer antipsychotic drugs were
estimated to cost over US$6000 per year.14 Similarly in Brazil,
treatment with older, first-generation antipsychotic drugs is as
low as US$120 per patient per year, but second-generation drugs
cost over US$4000 per person annually.15 In Thailand, direct
medical costs for drug treatment in combination with family
interventions cost US$764 per patient per year.16
Limitations
It is important to note that the costing approach and underlying
tool used for this analysis does not provide any information on
the impact of scaled-up investment on health or other outcomes
resulting from MHCP implementation. Prospective assessment
of health and economic outcomes forms an integral part of
ongoing cohort studies being carried out in each PRIME site,
and results from these studies will likely necessitate a refinement
of the intervention care package elements and costs examined
here; a comparison of planned v. actual expenditures is planned.
Similarly, it will only be possible to compare the actual v.
predicted deployment of human resources once district-level
MHCPs have been fully implemented; until that time, estimates
provided here rely on the need for and level of care indicated
by each district’s MHCP, as well as the existing supply and
distribution of health workers at district level.
The costing tool used to generate the presented findings
has been designed to provide for extensive adaptation and
contextualisation (of selected disorders and interventions as well
as their resource inputs and expected coverage), while offering a
structured framework for putting together costed packages of care.
Such flexibility is not only important for reflecting variations in
service contexts or inputs between countries, but also within
countries, for example where there is a highly decentralised form
of government. However, the costing tool is unable to take proper
account of critical health system constraints to service scale up,
such as mid-term expenditure caps, supply-side bottlenecks to
recruiting staff or accessing essential medicines, and inadequate
referral and supervision mechanisms; such constraints have the
capacity to radically alter the actual level of programme
implementation or achievement. Even if such supply-side factors
were managed successfully, there is the additional concern that
demand for and actual uptake of available services does not match
desired levels of effective coverage. These deficiencies are to be
addressed via the development of a mental health module within
the inter-United Nations OneHealth tool, which will enable more
integrated planning by bringing together programme-specific
needs for mental health and other disease programmes with
shared health system components (such as human resource
planning and budgeting).
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